Key Features

• Good efficacy in terms of global patients assessment, postprandial fullness, and early satiety in the treatment of patients with FD
• Good alternative for the treatment of non-ulcer dyspepsia
• Unique dual mode of action
• Greater Tmax than Cisapride
• No effect on cardiovascular system
• No drug interactions

Indications

• Postprandial Fullness
• Bloating
• Gastroparesis
• Early Satiety
• Epigastric Pain
• Regurgitation
• Nausea and Vomiting
• Heartburn